Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

NCT05045664 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT05045664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
Lead sponsor
Heidelberg University
Phase
Phase 3
Overall status
Recruiting
Start date
July 6, 2022
Completion date
June 30, 2030
Enrollment
100 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

early stage follicular lymphoma who grade 1/2 or 3a